About the Authors
- Sven-Erik Bursell
-
Contributed equally to this work with: Sven-Erik Bursell, Stephanie J. Fonda, Drew G. Lewis, Mark B. Horton
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Telehealth Research Institute, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States of America
- Stephanie J. Fonda
-
Contributed equally to this work with: Sven-Erik Bursell, Stephanie J. Fonda, Drew G. Lewis, Mark B. Horton
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
Affiliation Estenda Solutions, Inc., Conshohocken, Pennsylvania, United States of America
- Drew G. Lewis
-
Contributed equally to this work with: Sven-Erik Bursell, Stephanie J. Fonda, Drew G. Lewis, Mark B. Horton
Roles Data curation, Investigation, Methodology, Software, Validation, Writing – review & editing
Affiliation Estenda Solutions, Inc., Conshohocken, Pennsylvania, United States of America
- Mark B. Horton
-
Contributed equally to this work with: Sven-Erik Bursell, Stephanie J. Fonda, Drew G. Lewis, Mark B. Horton
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
* E-mail: markhrtn@msn.com
Affiliation Phoenix Indian Medical Center, Phoenix, Arizona, United States of America
Competing Interests
We have the following interests. Sven-Erik Bursell is a scientific consultant for SocialEyes Corp. and Estenda Solutions Inc. Stephanie Fonda is Vice President for Research, Estenda Solutions Inc. Drew Lewis is President, Estenda Solutions Inc. Estenda Solutions Inc. is subcontracted by the Indian Health Service Tele-retinal program to provide required infrastructure and technology support. Mark B. Horton is a federal employee of the Indian Health Service and has no other financial disclosures. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.